Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-23

Clinical Trial Update: A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing bevacizumab-containing regimens with either gemcitabine or oxaliplatin, both combined with 5-fluorouracil and folinic acid,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-FU (5-fluorouracil)
  • Avastin (bevacizumab)
  • Folinic acid (folinic acid)
  • Gemzar (gemcitabine)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-12-23